Correlation Between Biomarin Pharmaceutical and Alnylam Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Biomarin Pharmaceutical and Alnylam Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomarin Pharmaceutical and Alnylam Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomarin Pharmaceutical and Alnylam Pharmaceuticals, you can compare the effects of market volatilities on Biomarin Pharmaceutical and Alnylam Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomarin Pharmaceutical with a short position of Alnylam Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomarin Pharmaceutical and Alnylam Pharmaceuticals.
Diversification Opportunities for Biomarin Pharmaceutical and Alnylam Pharmaceuticals
-0.22 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Biomarin and Alnylam is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Biomarin Pharmaceutical and Alnylam Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alnylam Pharmaceuticals and Biomarin Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomarin Pharmaceutical are associated (or correlated) with Alnylam Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alnylam Pharmaceuticals has no effect on the direction of Biomarin Pharmaceutical i.e., Biomarin Pharmaceutical and Alnylam Pharmaceuticals go up and down completely randomly.
Pair Corralation between Biomarin Pharmaceutical and Alnylam Pharmaceuticals
Given the investment horizon of 90 days Biomarin Pharmaceutical is expected to under-perform the Alnylam Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Biomarin Pharmaceutical is 2.02 times less risky than Alnylam Pharmaceuticals. The stock trades about -0.17 of its potential returns per unit of risk. The Alnylam Pharmaceuticals is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest 24,055 in Alnylam Pharmaceuticals on November 9, 2024 and sell it today you would earn a total of 3,770 from holding Alnylam Pharmaceuticals or generate 15.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals
Performance |
| Timeline |
| Biomarin Pharmaceutical |
| Alnylam Pharmaceuticals |
Biomarin Pharmaceutical and Alnylam Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biomarin Pharmaceutical and Alnylam Pharmaceuticals
The main advantage of trading using opposite Biomarin Pharmaceutical and Alnylam Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomarin Pharmaceutical position performs unexpectedly, Alnylam Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alnylam Pharmaceuticals will offset losses from the drop in Alnylam Pharmaceuticals' long position.| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
| Alnylam Pharmaceuticals vs. ProQR Therapeutics BV | Alnylam Pharmaceuticals vs. Wave Life Sciences | Alnylam Pharmaceuticals vs. Blueprint Medicines Corp | Alnylam Pharmaceuticals vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |